Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mastalgia-oil in Severe Mastalgia
NCT06966245Phase 3Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in mastalgia (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Mastalgia clinical response rate. Started Jun 2025; status: recruiting.
02
Conditions
mastalgia
Beyond the preview
Go deeper on NCT06966245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06966245.